The Role of Platelet/Endothelial Cell Adhesion Molecule–1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells
Open Access
- 15 September 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (18), 8624-8632
- https://doi.org/10.1158/0008-5472.can-07-0402
Abstract
In acute myelogenous leukemia (AML), leukemic cell-microenvironment interactions within various niches (stromal/osteoblastic or sinusoidal endothelial cell niches) have a role in leukemia cell survival and drug resistance. The AML leukemic cells express platelet/endothelial cell adhesion molecule–1 (CD31) and CD38, two adhesion molecules that could interact with microenvironmental elements, i.e., CD31 on the surface of marrow endothelial cells (CD31/CD31 and CD38/CD31 interactions) and hyaluronate (CD38/hyaluronate interactions). We report a physical association of these two antigens on the plasma membrane of myeloid leukemic cells. In this context, in vitro experiments done using interaction-blocking anti-CD31 and anti-CD38 monoclonal antibodies (CLB-HEC75 and OKT10, respectively) indicate that an excess of CD31 on the cell membrane of leukemic cells (CD31/CD38 MFI ratio >1) promotes a homotypic interaction with marrow endothelial cells, resulting in higher transendothelial migration. Conversely, an excess of CD38 (CD31/CD38 MFI ratio in vitro using fluorescence resonance energy transfer, co-capping, and co-immunoprecipitation experiments, and hyaluronate adhesion and transendothelial migration assays, are supported by immunophenotypic characterization of marrow leukemic cells from 78 AML patients on which CD38 expression levels were found to be positively correlated with those of CD31. Importantly, the excess of CD31 in those samples was associated with a higher peripheral WBC count. These findings indicate that bone marrow retention of AML cells depends on CD31 and CD38 coexpression levels. [Cancer Res 2007;67(18):8624–32]Keywords
This publication has 41 references indexed in Scilit:
- In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemiaBlood, 2006
- CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemiaThe FASEB Journal, 2006
- The stem cell niches in boneJCI Insight, 2006
- CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrowBlood, 2004
- Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell deathOncogene, 2003
- CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cellsBlood, 2003
- Adhesion Molecules Involved in Transendothelial Migration of Human Hematopoietic Progenitor CellsThe International Journal of Cell Cloning, 2000
- Cell Surface Antigen CD38 Identified as Ecto-Enzyme of NAD Glycohydrolase Has Hyaluronate-Binding ActivityBiochemical and Biophysical Research Communications, 1994
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990